The Cameroon 2008 Burkitt Lymphoma Protocol: Improved Event-Free Survival with Treatment Adapted to Disease Stage and the Response to Induction Therapy

REFERENCES

• Burkitt D. A sarcoma involving the jaw in children. Br J Surg. 1958;46:218–223.
   PubMed Web of Science ®Google Scholar
• Wakabi B. Special Report: Kenya and Uganda grapple with Burkitt lymphoma. Lancet Oncology 2008;9:319.
   PubMed Web of Science ®Google Scholar
• Parkin DM, Kramarova E, Draper GJ, , eds. International Incidence of Childhood Cancer, Volume II. IARC Scientific Publications No. 144. Lyon: IARC; 1998:34, 54.
   Google Scholar
• Sinfield RL, Molyneux EM, Banda K, Spectrum and presentation of pediatric malignancies in the HIV era; experience from Blantyre, Malawi, 1998–2003. Pediatr Blood Cancer. 2006;45:512–520.
   Google Scholar
• Burkitt D, Hunt MSR, Wright DH. The African lymphoma. Preliminary observations on response to therapy. Cancer. 1965;18:399–410.
   PubMed Web of Science ®Google Scholar
• Ziegler JL, Morrow R, Fass L, Treatment of Burkitt's tumor with cyclophosphamide. Cancer. 1970;26:474–484.
   PubMed Web of Science ®Google Scholar
• Kazembe P, Hesseling PB, Griffin BE, Long term survival of children with Burkitt lymphoma in Malawi after cyclophosphamide monotherapy. Med Pediatr Oncol. 2003;40:23–25.
   PubMedGoogle Scholar
• Nkrumah FK, Neequaye JE, Biggar R. Intrathecal chemoprophylaxis in the prevention of central nervous system relapse in Burkitt's lymphoma. Cancer. 1985;56:239–242.
   PubMed Web of Science ®Google Scholar
• Hesseling P, Molyneux E, Tchintseme F, Oral cyclophosphamide and intrathecal methotrexate in 140 children with Burkitt lymphoma. Pediatr Blood Cancer. 2006;47(abstract):381.
   Google Scholar
• Hesseling PB. Burkitt lymphoma treatment: the Malawi experience. J Afr Cancer. 2009;1:72– 79.
   Google Scholar
• Traoré F, Coze C, Atteby JA, Cyclophosphamide monotherapy in children with Burkitt lymphoma: a study from the French-African Pediatric Oncology Group (FAPOG). Pediatr Blood Cancer. 2011;56:70–76.
   PubMed Web of Science ®Google Scholar
• Hesseling PB, Molyneux E, Kamiza S, Broadhead R. Rescue chemotherapy for patients with relapsed or resistant endemic Burkitt's lymphoma. Trans R Soc Trop Med Hyg. 2008;102:602–607.
   PubMed Web of Science ®Google Scholar
• Patte C, Auperin A, Michon J, The Société Française d'Oncologie Pédiatrique LMB 89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukaemia. Blood. 2001;97:3370–3379.
   PubMed Web of Science ®Google Scholar
• Reiter A, Schrappe M, Tieman M, Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90. Blood. 1999;94:3294–3306.
   PubMed Web of Science ®Google Scholar
• Razack R, Michelow P, Leiman G, An interinstitutional review of the value of FNAB in paediatric oncology in resource limited countries. Diagn Cytopathol. 2011;xx:xx–xx; DOI:10.1002/dc 21624.
   Google Scholar
• Marjerrison S, Fernandes CV, Price VE, The use of ultrasound in endemic Burkitt lymphoma in Cameroon. Pediatr Blood Cancer. 2011;58:352–355.
   PubMed Web of Science ®Google Scholar
• Hesseling P, McCormick P, Kouya F, Burkitt lymphoma: residual abdominal tumor volume after induction correlates with outcome. Pediatr Blood Cancer. 2010;55:761–762.
   PubMed Web of Science ®Google Scholar
• Murphy SB. Classification, staging, and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults. Semin Oncol. 1980;7:332–339.
   PubMed Web of Science ®Google Scholar
• Hesseling PB, Broadhead R, Molyneux E, Malawi pilot study of Burkitt lymphoma treatment. Med Pediatr Oncol. 2003; 41:532–540.
   PubMedGoogle Scholar
• Hesseling PB, Molyneux E, Kamiza S, Endemic Burkitt lymphoma: a 28-day treatment schedule with cyclophosphamide and intrathecal methotrexate. Ann Trop Paediatr. 2009;29:29–34.
   PubMed Web of Science ®Google Scholar
• Magrath IT. African Burkitt's lymphoma. History, biology, clinical features, and treatment. Am J Pediatr Hematol Oncol. 1991;13:222–246.
   PubMedGoogle Scholar
• Nkrumah FK, Perkens IV. Burkitt's lymphoma: a clinical study of 110 patients. Cancer. 1976;37: 671–676.
   PubMed Web of Science ®Google Scholar
• Israëls T, van de Wetering MD, Hesseling P, Malnutrition and neutropenia in children treated for Burkitt lymphoma in Malawi. Pediatr Blood Cancer. 2009;53:47–52.
   PubMed Web of Science ®Google Scholar
• De Boer JD, Boellaard TN, Parkinson S, Patient compliance in the treatment of Burkitt's lymphoma in rural Zambia: a retrospective study on 80 Burkitt's lymphoma patients in Katete, rural Zambia. Afr J Paediatr Surg. 2009;6:3–6.
   PubMedGoogle Scholar
• Meremikwu MM, Ehiri EJ, Nkanga DC, Socioeconomic constraints to effective management of Burkitt's lymphoma in South Eastern Nigeria. Trop Med Int Health. 2005;10:92–98.
   PubMed Web of Science ®Google Scholar